This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Nancy Burton Esterly, MD; Joel S. Koransky, MD; Nancy L. Furey, MD; Maurizio Trevisan, MD

Arch Dermatol. 1984;120(10):1308-1313.

Abstract
• The effect of zymosan-activated serum samples, obtained from patients with acne who were receiving oral tetracycline hydrochloride therapy, on the chemotaxis and random migration of autologous polymorphonuclear leukocytes (PMNLs) and PMNLs from control donors was assayed in a Sykes-Moore chamber by a double-filter technique. Cells incubated with autologous serum specimens from these patients demonstrated significant suppression of both random migration and chemotaxis, with the greatest effect seen at a dosage of 1 g daily and a significant effect found at all dosage levels. When zymosan-activated serum samples from these patients were assayed with control donor PMNLs, similar inhibitory effects were shown. Assays of control sera and PMNLs from tetracycline-treated patients with acne showed the least degree of inhibition of chemotaxis. Although the mechanism of action is unclear, tetracycline appears to have a direct effect on neutrophil movement.

(Arch Dermatol 1984;120:1308-1313)

Author Affiliations
From the Departments of Pediatrics (Dr Esterly), Dermatology (Drs Esterly, Koransky, and Furey), and Community Health and Preventive Medicine (Dr Trevisan), Northwestern University Medical School, Chicago.

Footnotes
Accepted for publication Feb 18, 1984.

Reprint requests to Children's Memorial Hospital, 2300 Children's Plaza, Chicago, IL 60614 (Dr Esterly).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Tetracyclines Modulate Protease-Activated Receptor 2-Mediated Proinflammatory Reactions in Epidermal Keratinocytes
Ishikawa et al.
Antimicrob. Agents Chemother. 2009;53:1760-1765.
ABSTRACT | FULL TEXT  

Randomized Double-Blind Trial of Prophylactic Oral Minocycline and Topical Tazarotene for Cetuximab-Associated Acne-Like Eruption
Scope et al.
JCO 2007;25:5390-5396.
ABSTRACT | FULL TEXT  

Minocycline for the Treatment of Ocular and Ocular Adnexal Sarcoidosis
Park et al.
Arch Ophthalmol 2007;125:705-709.
FULL TEXT  

Expert Committee Recommendations for Acne Management
Zaenglein and Thiboutot
Pediatrics 2006;118:1188-1199.
ABSTRACT | FULL TEXT  

Acne, Antibiotics, and Upper Respiratory Tract Infections
Chan and Shaw
Arch Dermatol 2005;141:1157-1158.
FULL TEXT  

Interference of Antibacterial Agents with Phagocyte Functions: Immunomodulation or ""Immuno-Fairy Tales""?
Labro
Clin. Microbiol. Rev. 2000;13:615-650.
ABSTRACT | FULL TEXT  

Therapy for Acne Vulgaris
Leyden
NEJM 1997;336:1156-1162.
FULL TEXT  

Nicotinamide and Tetracycline Therapy of Bullous Pemphigoid
Fivenson et al.
Arch Dermatol 1994;130:753-758.
ABSTRACT  

The Treatment of Bullous Pemphigoid With Tetracycline and Niacinamide: A Preliminary Report
Berk and Lorincz
Arch Dermatol 1986;122:670-674.
ABSTRACT